BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jul 12, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

XOMA 052: Updated Phase II data

Updated data from an open-label Phase II trial in 7 patients who presented with active exacerbations of uveitis despite receiving maximal doses of immunosuppressive medicines showed that a single IV infusion of 0.3 mg/kg...

Read the full 150 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >